Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OP-145 eardrops for chronic otitis media
ISRCTN84220089Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Mar 2004
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of OP-145 in chronic otitis media (COM) (6 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Safety of OP-145 eardrops at week 12. Started Mar 2004; status: completed.
02
Drugs
OP-145
03
Conditions
chronic otitis media (COM)
Beyond the preview
Go deeper on ISRCTN84220089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84220089.